SenoRx to Present at 2008 Southern California Investor Conference

IRVINE, CA–(EMWNews – August 25, 2008) – SenoRx, Inc. (NASDAQ: SENO) today announced that

President and Chief Executive Officer Lloyd Malchow will present a company

overview at the California Stock Report’s 2008 Southern California Investor

Conference at 9:00 a.m. Pacific Time on Wednesday, September 3, 2008 at The

Island Hotel in Newport Beach, Calif.

Interested parties may listen to the presentation through a live audio

webcast at www.californiastocks.com. Listeners are encouraged to visit the

Web site at least 15 minutes prior to the start of the scheduled

presentation to register, download and install any necessary audio

software.

About SenoRx

SenoRx (NASDAQ: SENO) develops, manufactures and sells minimally invasive

medical devices used by breast care specialists for the diagnosis and

treatment of breast cancer, including its EnCor® vacuum-assisted breast

biopsy system and Contura MLB catheter for delivering radiation to the

tissue surrounding the lumpectomy cavity following surgery for breast

cancer. SenoRx’s field sales organization serves over 1,000 breast

diagnostic and treatment centers in the United States and Canada. In

addition, SenoRx has recently launched several of its products through

distributors in more than 15 countries outside the U.S. and Canada. The

company’s line of breast care products includes biopsy disposables, biopsy

capital equipment, diagnostic adjunct products and therapeutic disposables.

SenoRx is developing additional minimally invasive products for the

diagnosis and treatment of breast cancer. For more information, visit the

company’s website at www.senorx.com.

About California Equity Research, LLC

Based in San Diego, California Equity Research, LLC is an independent

research-only firm focused exclusively on coverage of underfollowed

California-based equities. For more information, please visit the

California Equity Research website at www.calequityresearch.com.